期刊文献+

多囊卵巢综合征伴非酒精性脂肪性肝病患者雄激素水平改变的研究 被引量:1

Changes of androgen levels in polycystic ovary syndrome patients with non-alcoholic fatty liver disease
原文传递
导出
摘要 目的探讨多囊卵巢综合征(PCOS)伴非酒精性脂肪性肝病(NAFLD)患者血清睾酮(T)水平的改变。方法选取PCOS伴NAFLD(PCOS+NAFLD)组104例、单纯PCOS组142例、单纯NAFLD组40例和健康对照(NGT)组52名,比较各组临床指标水平,并对PCOS伴NAFLD患者的影响因素、血清T与其他指标的相关性及血清T的影响因素进行分析。结果与NGT、PCOS、NAFLD组相比,PCOS+NAFLD组BMI[(22.90±1.80)、(25.40±3.10)、(24.30±4.40)vs(28.30±4.20)kg/m2]、WHR[(0.74±0.06)、(0.82±0.09)、(0.81±0.16)vs(0.95±0.16)]、FPG[(5.18±0.32)、(5.96±0.46)、(5.10±0.48)vs(6.24±1.08)mmol/L]、FIns[(7.90±3.80)、(10.80±4.10)、(8.30±4.20)vs(12.30±5.70)mU/L]、TG[(1.40±0.90)、(2.00±1.80)、(2.30±1.60)vs(3.10±2.10)mmol/L]、T[(0.50±0.30)、(0.70±0.20)、(0.60±0.20)vs(1.10±0.60)μg/L]、胰岛素抵抗指数(HOMA-IR)[(1.90±1.30)、(3.10±0.60)、(3.40±0.90)vs(5.20±1.10)]升高,HDL-C[(1.69±0.40)、(1.44±0.33)、(1.12±0.38)vs(0.96±0.47)mmol/L]降低(P<0.05或P<0.01)。WHR、TG、HDL-C、HOMA-IR和T是PCOS伴发NAFLD的影响因素。BMI、FPG、FIns、HOMA-IR和黄体生成素(LH)是血清T水平的影响因素。结论 PCOS和NAFLD存在相关性,高雄激素血症是导致PCOS伴发NAFLD的危险因素,及早重视雄激素干预对防治PCOS伴发NAFLD有重要意义。 Objective To investigate the change of serum testosterone(T)level in polycystic ovary syndrome(PCOS)patients with non-alcoholic fatty liver disease(NAFLD). Methods The clinical data of 102 PCOS patients with NAFLD(PCOS+NAFLD group),142 PCOS patients without NAFLD(PCOS group),40 NAFLD patients without PCOS(NAFLD group)and 52 control subjects without both PCOS and NAFLD(NGT group)were collected.The clinical data of four groups were compared.Logistic analysis of influential factors for NAFLD genesis was performed in PCOS+ NAFLD group.Multiple regression analysis of T level forthe correlative factors was carried out. Results Compared with NGT,PCOS and NAFLD group,PCOS+NAFLD group showed significantly higher levels of BMI[(28.30±4.20)vs(22.90±1.80),(25.40±3.10),(24.30±4.40)kg/m^2],of WHR [(0.95±0.16)vs(0.74±0.06),(0.82±0.09),(0.81±0.16)],of FPG [(6.24±1.08)vs(5.18±0.32),(5.96±0.46),(5.10±0.48)mmol/L],of FIns[(12.30±5.70)vs(7.90±3.80),(10.80±4.10),(8.30±4.20)mU/L],of TG[(3.10±2.10)vs(1.40±0.90),(2.00±1.80),(2.30±1.60)mmol/L],of T [(1.10±0.60)vs(0.50±0.30),(0.70±0.20),(0.60±0.20)μg/L],of HOMA-IR [(5.20±1.10)vs(1.90±1.30),(3.10±0.60),(3.40±0.90)],and significantly lower HDL-C [(0.96±0.47)vs(1.69±0.40),(1.44±0.33),(1.12±0.38)mmol/L](P〈0.05 or P〈0.01).BMI,WHR,FPG,FIns,TG,LH and HOMA-IR were the influencing factors for T level. Conclusion PCOS and NAFLD have clinical correlation,hyperandrogenemiaisa risk factor of PCOS with NAFLD,early treatment of androgen is of important significance for preventing PCOS with NAFLD.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第2期123-126,共4页 Chinese Journal of Diabetes
关键词 多囊卵巢综合征 非酒精性脂肪性肝病 胰岛素抵抗 高雄激素血症 Polycystic ovary syndrome(PCOS) Non-alcoholic fatty liver disease(NAFLD) Insulin resistance(IR) Hyperandrogenemia
  • 相关文献

参考文献3

二级参考文献38

  • 1Fan, Jian-Gao,Peng, Yong-De.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):572-578. 被引量:42
  • 2范建高.糖尿病与肝病的关系及其诊治对策[J].中华糖尿病杂志,2009,1(4). 被引量:30
  • 3Welt CK, Gudmundsson JA, Arason G. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features. J Clin Endocrinol Metab,2006,91:4842-4848. 被引量:1
  • 4Ehrmann DA. Polycystic ovary syndrome N Engl J Med,2005, 352 : 1223-1236. 被引量:1
  • 5Setji TL, Brown AJ. Polycystic ovary syndrome: diagnosis and treatment. Am J Meal,2007, 120:128-132. 被引量:1
  • 6Essah PA, Nestler JE. The metabolic syndrome in polycysfic ovary syndrome. J Endocrinol Invest,2006,29:270-280. 被引量:1
  • 7Angulo P. Nonalcoholic fatty liver disease. N Engl J Med ,2002, 346 : 1221-1231. 被引量:1
  • 8Agarwal N, Sharma BC. Insulin resistance and clinical aspects of non-alcoholic steatohepatitis ( NASH ). Hepatol Res, 2005,33 : 92-96. 被引量:1
  • 9Setji TL, Holland ND, Sanders LL, et al. Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2006, 91:1741-1747. 被引量:1
  • 10Cerda C, Perez-Ayuso RM, Riquelme A, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol, 2007,47:412-417. 被引量:1

共引文献528

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部